The 3rd Annual Meeting of the International Academy for Clinical Hematology IACH: Focus on Leukemia, October 1-3, 2020, saw the discussion of key updates in the hemonc field with a focus on leukemia.
Highlights from this year’s IACH Annual Meeting include management of elderly leukemia, CAR T-cell therapy, rare leukemias as well as novel drugs.
First results of the 2nd H2H of iBTKs: the ALPINE study. With a 15 months follow up. So different population from ELEVATE RR #iwCLL2021 @PeterHillmen #CLL
Great talk on bispecific antibodies by Adrian Wiestner at the #iwCLL2021 meeting! 👨⚕️💉 Watch interviews with CLL experts here 👉http://ow.ly/vyi850GbSPz👈 @VJHemOnc @iwCLL #CLLsm #LEUsm #Leukemia 3
⭐@ninashah33 of @UofCalifornia gives us all the latest developments on the use of alloCAR-T therapies ⭐ Watch: 👉http://ow.ly/k1V050G7DAQ👈 @SocietyofHemOnc #SOHO2021 #HemOnc #ImmunoOnc #CART #BloodCancerAwarenessMonth #CancelBloodCancer #BCAM
In advance of our 2nd debate at #iwCLL2021 between Peter Dreger and @drjgauthier, which type of cellular therapy do you prefer for your patients with CLL?
Very nice description of a very difficult clinical situation: Richter’s Transformation with CNS involvement. Presented by @YucaiWangMD @WeiDing3 at #iwCLL2021
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates
Keep up to date with all the latest news with our monthly newsletter